1 - 3 of 3
1
Journal article icon

Journal article

A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome.

  • Ballard, CG, Thomas, A, Fossey, J, et al.
  • 2004-01-05
2
Journal article icon

Journal article

The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial.

  • Ballard, C, Hanney, ML, Theodoulou, M, et al.
  • 2009-02-05
3
Journal article icon

Journal article

A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial).

  • Ballard, C, Lana, MM, Theodoulou, M, et al.
  • 2008-04-05
FILTER RESULTS

TO TOP